August 16-22, 2010
Vail Marriott Mountain Resort & Spa
Vail, Colorado
E. Clarke Haley, MD
E. Clarke Haley, Jr., M.D. is Alumni Professor of Neurology and Neurological Surgery
at the University of Virginia School of Medicine in Charlottesville, VA. He has
been engaged in clinical trial work in acute stroke and subarachnoid hemorrhage
for over 25 years. He helped to pilot the development of recombinant tissue plasminogen
activator beginning in 1986 and was a member of the Steering Committee for the NINDS
TPA Stroke Trial. He was the Co-Principal Investigator of the Coordinating Center
for the Randomized Trial of Nicardipine in Subarachnoid Hemorrhage and both the
North American and European/Australian Trials of Tirilazad in Subarachnoid Hemorrhage.
He was also the Principal Investigator of the Coordinating Center of the Phase II
and III trials of Tirilazad in Acute Ischemic Stroke, as well as the North American
Phase II studies of gavestinel in acute ischemic stroke (GAIN). More recently, he
was the Principal Investigator for the early dose escalation and middle phase studies
of tenecteplase (TNK) in acute ischemic stroke.
APPLICATIONS DUE BY 3/26/2010
ACCEPTED PARTICIPANTS WILL RECEIVE FULL SCHOLARSHIPS FOR TUITION AND EXPENSES
|
Supported by the National Institute of Neurological Disorders and Stroke |
|